[HTML][HTML] Evaluation of synergism in drug combinations and reference models for future orientations in oncology

D Duarte, N Vale - Current Research in Pharmacology and Drug …, 2022 - Elsevier
Current cancer therapy includes a variety of strategies that can comprise only one type of
treatment or a combination of multiple treatments. Chemotherapy is still the gold standard for …

Active mitochondrial respiration in cancer: a target for the drug

M Bedi, M Ray, A Ghosh - Molecular and Cellular Biochemistry, 2022 - Springer
The relative contribution of mitochondrial respiration and subsequent energy production in
malignant cells has remained controversial to date. Enhanced aerobic glycolysis and …

Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML

C Liu, W Zou, D Nie, S Li, C Duan, M Zhou, P Lai… - Cell metabolism, 2022 - cell.com
Our group has reported previously on the role of various members of the protein arginine
methyltransferase (PRMT) family, which are involved in epigenetic regulation, in the …

[HTML][HTML] Baicalin; a promising chemopreventive agent, enhances the antitumor effect of 5-FU against breast cancer and inhibits tumor growth and angiogenesis in …

NH Shehatta, TM Okda, GA Omran… - Biomedicine & …, 2022 - Elsevier
Despite considerable advances in cancer treatment, chemotherapy remains a cornerstone
in breast cancer therapy. Therefore, reducing chemoresistance and adverse effects of …

Diosmetin exerts synergistic effects in combination with 5-fluorouracil in colorectal cancer cells

S Kamran, A Sinniah, Z Chik, MA Alshawsh - Biomedicines, 2022 - mdpi.com
5-Fluorouracil (5-FU) is a chemotherapeutic medication commonly used to treat colorectal
cancer (CRC); however, the drug-associated adverse effects and toxicity have greatly …

Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil

M Abid, M Naveed, I Azeem, A Faisal, MF Nazar… - International Journal of …, 2020 - Elsevier
Targeting bioactives selectively to diseased sites is one of the most challenging aspects of
cancer therapy. Herein, fabrication of colonic enzyme-responsive dextran based oligoester …

The natural isoflavone Biochanin‐A synergizes 5‐fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid‐phase carcinoma model

M Mahmoud, MRA Abdollah, ME Elsesy… - Phytotherapy …, 2022 - Wiley Online Library
Isoflavones are considered one of the most extensively studied plant‐derived
phytoestrogenic compounds. Of these, Biochanin A (Bio‐A), a natural isoflavone abundant …

Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway

Y Jin, DTN Huynh, KS Heo - Archives of pharmacal research, 2022 - Springer
Abstract Ginsenoside-Rh1 (Rh1) is a ginseng-derived compound that has been reported to
exert anticancer effects by regulating cell cycle arrest and apoptosis according to reactive …

A review of twenty years of research on the regulation of signaling pathways by natural products in breast cancer

M Naeem, MO Iqbal, H Khan, MM Ahmed, M Farooq… - Molecules, 2022 - mdpi.com
Breast cancer (BC) is the second leading cause of death among women, and it has become
a global health issue due to the increasing number of cases. Different treatment options …

Sp-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical …

F Pantano, S Simonetti, M Iuliani, MJ Guillen, C Cuevas… - Oncogene, 2024 - nature.com
Trabectedin, approved for the treatment of soft tissue sarcoma (STS), interferes with cell
division and genetic transcription processes. Due to its strong anti-tumor activity in only …